E-Scape Bio is a biopharmaceutical company focused on the discovery and development of small-molecule drugs to treat genetically-defined subpopulations in neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. The company's therapeutic programs are designed to restore normal function disrupted by inherited genetic mutations causing the disease.
Market
Neurodegenerative diseases
Location
South San Francisco,
California,
USA
Coinvestors
Johnson & Johnson Development Corporation (JJDC), Lilly Asia Ventures, Novartis Venture Funds, Novo A/S, OrbiMed Advisors, Osage University Partners, Sutter Hill Ventures